Overview


According to FutureWise analysis the market for long read sequencing in 2023 is US$ 0.9 billion, and is expected to reach US$ 4.57 billion by 2031 at a CAGR of 22.52%.

Long-read sequencing is a type of DNA sequencing technique. Third-generation sequencing is another name for it. Long read sequencing technique aids in overcoming and coping with throughput, widening, and precise application limits in genomics. It has a number of benefits over short-read sequencing. In compared to short-read sequencers, which produce up to 600 bases of DNA, long read sequencing technology can generate reads of more than 10,000 bases. The widespread application of this technology will improve our understanding of pathogen development, cancer, genetic diversity, and drug resistance in complicated genome regions that are crucial for clinical care. The market for alopecia areata is being driven by an increase in incidence of type 1 diabetes and rheumatoid arthritis. The alopecia areata market will develop due to an increase in autoimmune diseases and a family history of hair-related problems. Furthermore, the worldwide alopecia areata market will benefit from growing prevalence of autoimmune conditions such as type 1 diabetes and rheumatoid arthritis, as well as the development of novel therapies for treatment. However, in poorer nations, a lack of patient understanding of diseases and homemade therapy without recognising the negative effects may stymie the global alopecia areata market. Long-read sequencing technologies are rapidly moving toward support of high resolution histocompatibility leucocyte antigen (HLA) typing for transplant registries in certain regions, as high resolution typing has the potential to improve organ matching and clinical outcomes of patients undergoing transplantation.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Long Read Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Long Read Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Limited
  • Quantapore, Inc.
  • Stratos Genomics Inc.
  • MicrobesNG
  • Institute of Integrative Biology of the Cell (I2BC)
  • BaseClear B.V.
  • Future Genomics Technologies B.V.
  • Garvan Institute of Medical Research
  • Genome Transcriptome Facility of Bordeaux
  • NextOmics
  • Takara Bio Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

By Product

  • Instruments
  • Consumables
  • Services

By Application

  • Identification and fine mapping of structural variation
  • Tandem Repeat Sequencing
  • Pseudogene discrimination
  • Resolving allele phasing
  • Reproductive genomics
  • Cancer
  • Viral and Microbial Sequencing
  • Others

By Workflow

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By End-use

  • Academic Research
  • Clinical Research
  • Hospitals and Clinics
  • Pharma and Biotech Entities
  • Other

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Long Read Sequencing Market By Technology, By Product, By Application, By Workflow, By End-use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Long Read Sequencing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Long Read Sequencing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Long Read Sequencing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Long Read Sequencing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Single-Molecule Real-Time Sequencing (SMRT)
        2. Nanopore Sequencing

  • 8.   Long Read Sequencing Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
        2. Consumables
        3. Services

  • 9.   Long Read Sequencing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Identification and fine mapping of structural variation
        2. Tandem Repeat Sequencing
        3. Pseudogene discrimination
        4. Resolving allele phasing
        5. Reproductive genomics
        6. Cancer
        7. Viral and Microbial Sequencing
        8. Others

  • 10.   Long Read Sequencing Market, By Workflows Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pre-sequencing
        2. Sequencing
        3. Data Analysis

  • 11.   Long Read Sequencing Market, By End-use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma and Biotech Entities
        5. Other

  • 12.   North America Long Read Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Long Read Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Long Read Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Long Read Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pacific Biosciences of California, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Oxford Nanopore Technologies Limited
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Quantapore, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Stratos Genomics Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. MicrobesNG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Institute of Integrative Biology of the Cell (I2BC)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. BaseClear B.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Future Genomics Technologies B.V.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Garvan Institute of Medical Research
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Genome Transcriptome Facility of Bordeaux
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. NextOmics
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Takara Bio Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients